Castro Gisele A, Ferreira Lucas Am
Federal University of Minas Gerais, Department of Pharmaceutics, 31270-901, Belo Horizonte, Minas Gerais, Brazil.
Expert Opin Drug Deliv. 2008 Jun;5(6):665-79. doi: 10.1517/17425247.5.6.665.
The efficacy of the antiacne topical drugs is well established. The local side effects, however, mainly cutaneous irritation, erythema, dryness, peeling and scaling, remain major problems. Novel vesicular and particulate drug delivery systems have been proposed to reduce the side effects of drugs commonly used in the topical treatment of acne.
This review focuses on the development and evaluation of antiacne drug-loaded vesicular and particulate delivery systems (liposomes, polymeric microspheres and solid lipid nanoparticles) for topical treatment, their advantages and challenges.
All the literature available was reviewed to highlight the potential of these novel systems for the topical treatment of acne.
The encapsulation of antiacne drugs in vesicular and particulate delivery systems represents an innovative alternative to minimize side effects, while preserving their efficacy. This can be obtained by the capacity of these systems to provide controlled release or to improve the drug penetration into skin or even into the pilosebaceous unit.
抗痤疮局部用药的疗效已得到充分证实。然而,局部副作用,主要是皮肤刺激、红斑、干燥、脱皮和脱屑,仍然是主要问题。已提出新型囊泡和颗粒药物递送系统,以减少痤疮局部治疗中常用药物的副作用。
本综述重点关注用于局部治疗的载有抗痤疮药物的囊泡和颗粒递送系统(脂质体、聚合物微球和固体脂质纳米粒)的开发与评价、它们的优势及挑战。
查阅所有可得文献,以突出这些新型系统在痤疮局部治疗中的潜力。
将抗痤疮药物封装于囊泡和颗粒递送系统中是一种创新的选择,可在保持疗效的同时将副作用降至最低。这可通过这些系统提供控释的能力或改善药物渗透至皮肤甚至毛囊皮脂腺单位来实现。